ON PHOTOPHERESIS EFFICIENCY IN ANETODERMIA


如何引用文章

全文:

详细

Extracorporeal photochemotherapy — photopheresis — was used for the treatment of anetodermia. A pronounced clinical effect (4 sessions every other day) was attained in the treatment of Schwenninger-Buzzi’a anetodermia (developing in the presence of Lewandowsky-Lutz verruciform epidermodysplasia) and Jadassohn ’s anetodermia. Photopheresis induced a trend to normalization of some immunological parameters. This is the first in world literature report about pronounced clinical efficiency and pathogenetic nature of photopheresis in anetodermia.

作者简介

V. Molochkov

M.F. Vladimirsky Moscow Regional Research and Clinical Institute

заслуженный деятель науки, доктор мед. наук, профессор Отделение дерматовенерологии и дерматоонкологии

O. Karzanov

M.F. Vladimirsky Moscow Regional Research and Clinical Institute

кандидат мед. наук, старший научный сотрудник Отделение дерматовенерологии и дерматоонкологии

A. Prokofyev

M.F. Vladimirsky Moscow Regional Research and Clinical Institute

Email: alex-prok3@mail.ru
младший научный сотрудник Отделение дерматовенерологии и дерматоонкологии

Yu. Molochkova

M.F. Vladimirsky Moscow Regional Research and Clinical Institute

клинический ординатор Отделение дерматовенерологии и дерматоонкологии

参考

  1. Thomas J.E., Mehregan D.R., Holland J., Mehregan D.A. Familial anetoderma. Int. J. Dermatol. 2003; 42(1): 75—7.
  2. Kineston D.P., Xia Y., Turiansky G.W. Anetoderma: a case report and review of the literature. Cutis. 2008; 81(6): 501—6.
  3. Sparsa A., Piette J.C., Wechsler B., Amoura Z., Franc S.C. Anetoderma and its prothrombotic abnormalities. J. Am. Acad. Dermatol. 2003; 49(6): 1008—12.
  4. Braun R.P., Borradori L., Chavaz R., Masouye I., French L., Saurat J.H. Treatment of primary anetoderma with colchicines. J. Am. Acad. Dermatol. 1998; 38(6, Pt 1): 1002—3.
  5. Молочков В.А., Кочеткова Л.А., Прокофьев А.А. Анетодермия. Сборник статей научно-практической конференции «Актуальные вопросы дерматовенерологии и дерматоонкологии», 27—28 мая 2010, Москва. 2010: 17—9.
  6. Edelson R.L. Photopheresis: a clinical relevant immunobiologic response modifier. Ann. N. Y Acad. Sci. 1991; 636: 154—64.
  7. Lee K.H., Garro J. Engineering aspects of extracorporeal photochemotherapy. Yale J. Biol. Med. 1989; 62(6): 621—8.
  8. Vowels B.R., Cassin M., Boufal M.H., Walsh L.J., Rook A.H. Extracorporeal phothochemotherapy induces the production of tumor necrosis factor alpfa by monocytes: implications for the treatment of cutaneous T-cell lymphoma and systemic sclerosis. J. Invest. Dermatol. 1992; 98(5): 686—92.
  9. Zic J., Arzubiaga C., Salhany K.E., Parker R.A., Wilson D., Stricklin G.P., et al. Extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma. J. Am. Acad. Dermatol. 1992; 27(5, Pt 1): 729—36.
  10. Gerber M., Gmeinhart B., Volc-Platzer B., Kalhs P., Greinix H.T., Knobler R. Complete remission of lichen-planus-like graft-versus-host disease (GVHD) with extracorporeal photochemotherapy (ESP). Bone Mаrrow Transplant. 1997; 19(5): 517—9.
  11. Greinix H.T., Volc-Platzer B., Rabitsch W., Gmeinhart B., Guevara-Pineda C., Kalhs P., еt al. Successful use of eхtracorporeal photochemotherapy in the treatment of severe acute and chronic graft-versus-host disease. Blood. 1998; 92(5): 3098—104.
  12. Owsianowski M., Gollnick H., Siegert W. Schwerdtfeger R., Orfanos C.E. Successful treatment of chronic graft-versus-host disease with extracorporeal photopheresis. Bone Marrow Transplant. 1994; 14(5): 845—8.
  13. Knobler R., Barr M.L., Couriel D.R., Ferrara J.L., French L.E., Jaksch P., et al. Extracorporeal photopheresis: past, present, and future. J. Am. Acad. Dermatol. 2009; 61(4): 652—65.

版权所有 © Eco-Vector, 2013


 


##common.cookie##